Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nasal spray sedation showdown: which drug works best for kids and adults?

NCT ID NCT07166666

Symptom relief Sponsor: Oman Medical Speciality Board Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests two different drug combinations given as a nasal spray to help patients relax during medical procedures. It includes 128 people aged 2 to 60 years old. The goal is to see which approach provides better sedation, faster recovery, and fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Midazolam, fentanyl, and dexmedetomidine (given via nasal spray atomizer)
What this could lead to
If it works, this could show that atomized sedation is a safe and effective option for both children and adults during medical procedures.
What could go wrong
This is a small, early-stage trial (128 participants) comparing different drugs, so results may not apply to all patients or settings. Side effects like breathing problems or allergic reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 128 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * inclusion criteria: 1. Patients aged 2 to 60 years. 2. Patients undergoing EM procedures requiring sedation. Exclusion criteria: 1. Patients with contraindications to any of the sedation agents being studied. 2. Patients with a history of adverse reactions or allergies to the study medications. 3. Drug interactions: Patients taking certain medications that may interact adversely with the study medications. 4. Drug Abuser 5. Pregnancy and breastfeeding 6. Patients with significant cardiovascular or respiratory compromise. 7. Patients with nasal disorder (nasal trauma, epistaxis) 8. Patients unable to provide informed consent or those with cognitive impairment. 9. Patients who are \< 2 year of age or \> 60 year of age. 10. Patient underwent procedure sedation for imaging

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Analgesia assessment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Analgesia assessment Sedation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • dr.Suad al baluish

    Muscat, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.